APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androgen Receptor (AR) Antagonist

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Androgen Receptor (AR) Antagonist Industry Growth and Trends Forecast to 2032

27 December 202590 pages

Choose your research edition.

Industry ResearchAndrogen Receptor (AR) Antagonist Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Androgen Receptor (AR) Antagonist Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Androgen Receptor (AR) Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androgen Receptor (AR) Antagonist Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Androgen Receptor (AR) Antagonist Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Androgen Receptor (AR) Antagonist market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Androgen Receptor (AR) Antagonist include Kaituo Pharmaceutical, Pfizer, Hengrui Medicine, Bayer, R&D Systems, Janssen Pharmaceuticals and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Androgen Receptor (AR) Antagonist market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Androgen Receptor (AR) Antagonist market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Androgen Receptor (AR) Antagonist market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Androgen Receptor (AR) Antagonist.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Androgen Receptor (AR) Antagonist market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Androgen Receptor (AR) Antagonist Market by Company

Kaituo Pharmaceutical

Pfizer

Hengrui Medicine

Bayer

R&D Systems

Janssen Pharmaceuticals

Astellas Pharma

Androgen Receptor (AR) Antagonist Segment by Type

Steroidal AR Antagonists

Nonsteroidal AR Antagonists

Androgen Receptor (AR) Antagonist Segment by Application

Prostate Cancer

Breast Cancer

Others

Androgen Receptor (AR) Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgen Receptor (AR) Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgen Receptor (AR) Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgen Receptor (AR) Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Androgen Receptor (AR) Antagonist manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Androgen Receptor (AR) Antagonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Steroidal AR Antagonists Table 2. Major Company of Nonsteroidal AR Antagonists Table 3. Global Androgen Receptor (AR) Antagonist Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 5. Global Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Type (2021-2026) Table 6. Global Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (US$ Million) Table 7. Global Androgen Receptor (AR) Antagonist Sales Market Share in Value by Type (2021-2026) Table 8. Global Androgen Receptor (AR) Antagonist Price by Type (2021-2026) & (US$/Ton) Table 9. Global Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 10. Global Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Type (2027-2032) Table 11. Global Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (US$ Million) Table 12. Global Androgen Receptor (AR) Antagonist Sales Market Share in Value by Type (2027-2032) Table 13. Global Androgen Receptor (AR) Antagonist Price by Type (2027-2032) & (US$/Ton) Table 14. North America Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 15. North America Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 17. Europe Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 19. Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 21. Latin America Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 23. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (US$ Million) Table 24. Androgen Receptor (AR) Antagonist Industry Trends Table 25. Androgen Receptor (AR) Antagonist Industry Drivers Table 26. Androgen Receptor (AR) Antagonist Industry Opportunities and Challenges Table 27. Androgen Receptor (AR) Antagonist Industry Restraints Table 28. Global Androgen Receptor (AR) Antagonist Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Company (2021-2026) Table 30. Global Androgen Receptor (AR) Antagonist Sales by Company (2021-2026) & (K Tons) Table 31. Global Androgen Receptor (AR) Antagonist Sales Share by Company (2021-2026) Table 32. Global Androgen Receptor (AR) Antagonist Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Androgen Receptor (AR) Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Androgen Receptor (AR) Antagonist Major Company Production Sites and Headquarters Table 35. Global Androgen Receptor (AR) Antagonist Company, Product Type & Application Table 36. Global Androgen Receptor (AR) Antagonist Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Androgen Receptor (AR) Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Androgen Receptor (AR) Antagonist Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Androgen Receptor (AR) Antagonist Sales by Region (2021-2026) & (K Tons) Table 41. Global Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Region (2021-2026) Table 42. Global Androgen Receptor (AR) Antagonist Sales by Region (2021-2026) & (US$ Million) Table 43. Global Androgen Receptor (AR) Antagonist Sales Market Share in Value by Region (2021-2026) Table 44. Global Androgen Receptor (AR) Antagonist Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Androgen Receptor (AR) Antagonist Sales by Region (2027-2032) & (K Tons) Table 46. Global Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Region (2027-2032) Table 47. Global Androgen Receptor (AR) Antagonist Sales by Region (2027-2032) & (US$ Million) Table 48. Global Androgen Receptor (AR) Antagonist Sales Market Share in Value by Region (2027-2032) Table 49. Global Androgen Receptor (AR) Antagonist Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Androgen Receptor (AR) Antagonist Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 52. Global Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Application (2021-2026) Table 53. Global Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (US$ Million) Table 54. Global Androgen Receptor (AR) Antagonist Sales Market Share in Value by Application (2021-2026) Table 55. Global Androgen Receptor (AR) Antagonist Price by Application (2021-2026) & (US$/Ton) Table 56. Global Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 57. Global Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Application (2027-2032) Table 58. Global Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (US$ Million) Table 59. Global Androgen Receptor (AR) Antagonist Sales Market Share in Value by Application (2027-2032) Table 60. Global Androgen Receptor (AR) Antagonist Price by Application (2027-2032) & (US$/Ton) Table 61. North America Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 62. North America Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 64. Europe Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 66. Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 68. Latin America Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 70. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (US$ Million) Table 71. Kaituo Pharmaceutical Company Information Table 72. Kaituo Pharmaceutical Business Overview Table 73. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio Table 75. Kaituo Pharmaceutical Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Pfizer Androgen Receptor (AR) Antagonist Product Portfolio Table 80. Pfizer Recent Development Table 81. Hengrui Medicine Company Information Table 82. Hengrui Medicine Business Overview Table 83. Hengrui Medicine Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio Table 85. Hengrui Medicine Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Bayer Androgen Receptor (AR) Antagonist Product Portfolio Table 90. Bayer Recent Development Table 91. R&D Systems Company Information Table 92. R&D Systems Business Overview Table 93. R&D Systems Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio Table 95. R&D Systems Recent Development Table 96. Janssen Pharmaceuticals Company Information Table 97. Janssen Pharmaceuticals Business Overview Table 98. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio Table 100. Janssen Pharmaceuticals Recent Development Table 101. Astellas Pharma Company Information Table 102. Astellas Pharma Business Overview Table 103. Astellas Pharma Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio Table 105. Astellas Pharma Recent Development Table 106. North America Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 107. North America Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 108. North America Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2026) Table 109. North America Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032) & (K Tons) Table 110. North America Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Country (2027-2032) Table 111. North America Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Androgen Receptor (AR) Antagonist Market Share by Country (2021-2026) Table 114. North America Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Androgen Receptor (AR) Antagonist Market Share Forecast by Country (2027-2032) Table 116. Europe Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 117. Europe Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 118. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2026) Table 119. Europe Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032) & (K Tons) Table 120. Europe Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Androgen Receptor (AR) Antagonist Market Share by Country (2021-2026) Table 124. Europe Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Androgen Receptor (AR) Antagonist Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 128. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032) & (K Tons) Table 130. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Androgen Receptor (AR) Antagonist Market Share by Country (2021-2026) Table 134. Asia-Pacific Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Androgen Receptor (AR) Antagonist Market Share Forecast by Country (2027-2032) Table 136. Latin America Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 137. Latin America Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 138. Latin America Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2026) Table 139. Latin America Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032) & (K Tons) Table 140. Latin America Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Androgen Receptor (AR) Antagonist Market Share by Country (2021-2026) Table 144. Latin America Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Androgen Receptor (AR) Antagonist Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 148. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032) & (K Tons) Table 150. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Androgen Receptor (AR) Antagonist Market Share by Country (2021-2026) Table 154. Middle East and Africa Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Androgen Receptor (AR) Antagonist Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Androgen Receptor (AR) Antagonist Distributors List Table 159. Androgen Receptor (AR) Antagonist Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Androgen Receptor (AR) Antagonist Image Figure 2. Global Androgen Receptor (AR) Antagonist Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androgen Receptor (AR) Antagonist Market Size (2021-2032) & (US$ Million) Figure 4. Global Androgen Receptor (AR) Antagonist Sales (2021-2032) & (K Tons) Figure 5. Steroidal AR Antagonists Image Figure 6. Global Steroidal AR Antagonists Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Nonsteroidal AR Antagonists Image Figure 8. Global Nonsteroidal AR Antagonists Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Global Androgen Receptor (AR) Antagonist Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Androgen Receptor (AR) Antagonist Market Share by Type 2025 VS 2032 Figure 11. North America Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Type in 2025 Figure 12. North America Androgen Receptor (AR) Antagonist Sales Market Share in Value by Type in 2025 Figure 13. Europe Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Type in 2025 Figure 14. Europe Androgen Receptor (AR) Antagonist Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Market Share in Value by Type in 2025 Figure 17. Latin America Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Androgen Receptor (AR) Antagonist Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Androgen Receptor (AR) Antagonist Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Prostate Cancer Image Figure 24. Global Prostate Cancer Sales YoY Growth (2021-2032) & (K Tons) Figure 25. Breast Cancer Image Figure 26. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Global Androgen Receptor (AR) Antagonist Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Androgen Receptor (AR) Antagonist Market Share by Application 2025 VS 2032 Figure 31. North America Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Application in 2025 Figure 32. North America Androgen Receptor (AR) Antagonist Sales Market Share in Value by Application in 2025 Figure 33. Europe Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Application in 2025 Figure 34. Europe Androgen Receptor (AR) Antagonist Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Market Share in Value by Application in 2025 Figure 37. Latin America Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Androgen Receptor (AR) Antagonist Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share in Value by Application in 2025 Figure 41. North America Androgen Receptor (AR) Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 42. North America Androgen Receptor (AR) Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Androgen Receptor (AR) Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Androgen Receptor (AR) Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Androgen Receptor (AR) Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 46. Europe Androgen Receptor (AR) Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Androgen Receptor (AR) Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Androgen Receptor (AR) Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 50. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Androgen Receptor (AR) Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Androgen Receptor (AR) Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Androgen Receptor (AR) Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 54. Latin America Androgen Receptor (AR) Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Androgen Receptor (AR) Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Androgen Receptor (AR) Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 58. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Androgen Receptor (AR) Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Androgen Receptor (AR) Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Androgen Receptor (AR) Antagonist Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Androgen Receptor (AR) Antagonist Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Steroidal AR Antagonists
  • Nonsteroidal AR Antagonists
Applications
  • Prostate Cancer
  • Breast Cancer
  • Others
Companies covered
  • Kaituo Pharmaceutical
  • Pfizer
  • Hengrui Medicine
  • Bayer
  • R&D Systems
  • Janssen Pharmaceuticals
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Androgen Receptor (AR) Antagonist Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Androgen Receptor (AR) Antagonist Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Androgen Receptor (AR) Antagonist Market by Type
  6. 1.3.1 Steroidal AR Antagonists
  7. 1.3.2 Nonsteroidal AR Antagonists
  8. 1.4 Global Androgen Receptor (AR) Antagonist Market Size by Type
  9. 1.4.1 Global Androgen Receptor (AR) Antagonist Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Androgen Receptor (AR) Antagonist Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Androgen Receptor (AR) Antagonist Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Androgen Receptor (AR) Antagonist Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Androgen Receptor (AR) Antagonist Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Androgen Receptor (AR) Antagonist Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Androgen Receptor (AR) Antagonist Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Androgen Receptor (AR) Antagonist Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Androgen Receptor (AR) Antagonist Industry Trends
  2. 2.2 Androgen Receptor (AR) Antagonist Industry Drivers
  3. 2.3 Androgen Receptor (AR) Antagonist Industry Opportunities and Challenges
  4. 2.4 Androgen Receptor (AR) Antagonist Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Androgen Receptor (AR) Antagonist Revenue (2021-2026)
  2. 3.2 Global Top Players by Androgen Receptor (AR) Antagonist Sales (2021-2026)
  3. 3.3 Global Top Players by Androgen Receptor (AR) Antagonist Price (2021-2026)
  4. 3.4 Global Androgen Receptor (AR) Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Androgen Receptor (AR) Antagonist Major Company Production Sites & Headquarters
  6. 3.6 Global Androgen Receptor (AR) Antagonist Company, Product Type & Application
  7. 3.7 Global Androgen Receptor (AR) Antagonist Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Androgen Receptor (AR) Antagonist Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Androgen Receptor (AR) Antagonist Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Androgen Receptor (AR) Antagonist Tier 1, Tier 2, and Tier 3
4 Androgen Receptor (AR) Antagonist Regional Status and Outlook
  1. 4.1 Global Androgen Receptor (AR) Antagonist Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Androgen Receptor (AR) Antagonist Historic Market Size by Region
  3. 4.2.1 Global Androgen Receptor (AR) Antagonist Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Androgen Receptor (AR) Antagonist Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Androgen Receptor (AR) Antagonist Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Androgen Receptor (AR) Antagonist Forecasted Market Size by Region
  7. 4.3.1 Global Androgen Receptor (AR) Antagonist Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Androgen Receptor (AR) Antagonist Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Androgen Receptor (AR) Antagonist Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Androgen Receptor (AR) Antagonist by Application
  1. 5.1 Androgen Receptor (AR) Antagonist Market by Application
  2. 5.1.1 Prostate Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Others
  5. 5.2 Global Androgen Receptor (AR) Antagonist Market Size by Application
  6. 5.2.1 Global Androgen Receptor (AR) Antagonist Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Androgen Receptor (AR) Antagonist Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Androgen Receptor (AR) Antagonist Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Androgen Receptor (AR) Antagonist Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Androgen Receptor (AR) Antagonist Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Androgen Receptor (AR) Antagonist Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Androgen Receptor (AR) Antagonist Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Androgen Receptor (AR) Antagonist Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Kaituo Pharmaceutical
  2. 6.1.1 Kaituo Pharmaceutical Company Information
  3. 6.1.2 Kaituo Pharmaceutical Business Overview
  4. 6.1.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio
  6. 6.1.5 Kaituo Pharmaceutical Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Androgen Receptor (AR) Antagonist Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Hengrui Medicine
  14. 6.3.1 Hengrui Medicine Company Information
  15. 6.3.2 Hengrui Medicine Business Overview
  16. 6.3.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio
  18. 6.3.5 Hengrui Medicine Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Androgen Receptor (AR) Antagonist Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 R&D Systems
  26. 6.5.1 R&D Systems Company Information
  27. 6.5.2 R&D Systems Business Overview
  28. 6.5.3 R&D Systems Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio
  30. 6.5.5 R&D Systems Recent Developments
  31. 6.6 Janssen Pharmaceuticals
  32. 6.6.1 Janssen Pharmaceuticals Company Information
  33. 6.6.2 Janssen Pharmaceuticals Business Overview
  34. 6.6.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio
  36. 6.6.5 Janssen Pharmaceuticals Recent Developments
  37. 6.7 Astellas Pharma
  38. 6.7.1 Astellas Pharma Company Information
  39. 6.7.2 Astellas Pharma Business Overview
  40. 6.7.3 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio
  42. 6.7.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Androgen Receptor (AR) Antagonist Sales by Country
  2. 7.1.1 North America Androgen Receptor (AR) Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Androgen Receptor (AR) Antagonist Sales by Country (2021-2026)
  4. 7.1.3 North America Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032)
  5. 7.2 North America Androgen Receptor (AR) Antagonist Market Size by Country
  6. 7.2.1 North America Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026)
  8. 7.2.3 North America Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Androgen Receptor (AR) Antagonist Sales by Country
  2. 8.1.1 Europe Androgen Receptor (AR) Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Androgen Receptor (AR) Antagonist Sales by Country (2021-2026)
  4. 8.1.3 Europe Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Androgen Receptor (AR) Antagonist Market Size by Country
  6. 8.2.1 Europe Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026)
  8. 8.2.3 Europe Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Country
  2. 9.1.1 Asia-Pacific Androgen Receptor (AR) Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Androgen Receptor (AR) Antagonist Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Androgen Receptor (AR) Antagonist Market Size by Country
  6. 9.2.1 Asia-Pacific Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Androgen Receptor (AR) Antagonist Sales by Country
  2. 10.1.1 South America Androgen Receptor (AR) Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Androgen Receptor (AR) Antagonist Sales by Country (2021-2026)
  4. 10.1.3 South America Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032)
  5. 10.2 South America Androgen Receptor (AR) Antagonist Market Size by Country
  6. 10.2.1 South America Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026)
  8. 10.2.3 South America Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country
  2. 11.1.1 Middle East and Africa Androgen Receptor (AR) Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Androgen Receptor (AR) Antagonist Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Androgen Receptor (AR) Antagonist Market Size by Country
  6. 11.2.1 Middle East and Africa Androgen Receptor (AR) Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Androgen Receptor (AR) Antagonist Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Androgen Receptor (AR) Antagonist Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Androgen Receptor (AR) Antagonist Value Chain Analysis
  2. 12.1.1 Androgen Receptor (AR) Antagonist Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Androgen Receptor (AR) Antagonist Production Mode & Process
  7. 12.2 Androgen Receptor (AR) Antagonist Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Androgen Receptor (AR) Antagonist Distributors
  10. 12.2.3 Androgen Receptor (AR) Antagonist Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst